select a format

Single User License
USD 250 INR 16040
Site License
USD 500 INR 32080
Corporate User License
USD 750 INR 48120

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


ProMIS Neurosciences Inc (PMN)-Medical Equipment-Deals and Alliances Profile

ProMIS Neurosciences Inc (PMN)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME14743D
  • |
  • Pages: 50
  • |
  • April 2017
  • |
  • |
  Request for Sample Report

Executive Summary

ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company developed two new technologies, namely, Epitope Protection and AMFIA for identifying low levels of misfolded proteins in the biological samples which helped in generating cerebrospinal fluid screening test for Alzheimer's disease. The company's products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. ProMIS is headquartered in Toronto Ontario, Canada.

ProMIS Neurosciences Inc (PMN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

ProMIS Neurosciences Inc, Medical Equipment, Deal Details 11

Partnerships 11

Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11

Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 12

Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 13

Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 13

Equity Offering 14

ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 14

ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 16

ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 17

ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 18

ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 19

Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 20

Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 21

Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 22

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 23

Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 24

Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 25

Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 25

Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 26

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 27

Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 28

ProMIS Neurosciences Inc-Key Competitors 31

Key Employees 32

Locations And Subsidiaries 33

Head Office 33

Recent Developments 34

Financial Announcements 34

Mar 30, 2017: ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation 34

Mar 15, 2017: ProMIS Neurosciences Announces Fiscal 2016 Annual Results 35

Nov 02, 2016: ProMIS Neurosciences Announces Third Quarter 2016 Results 37

Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results 39

May 11, 2016: ProMIS Neurosciences announces first quarter 2016 results 41

Mar 23, 2016: ProMIS Neurosciences announces FY2015 year end results 42

Corporate Communications 45

Mar 22, 2017: ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer 45

Mar 02, 2017: ProMIS Neurosciences announces appointment of Anthony Giovinazzo to its Board of Directors 46

Oct 18, 2016: ProMIS Neurosciences announces appointment of Dr. Richard Gregory to its Board of Directors 47

Jul 21, 2016: ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer 48

Jan 26, 2016: ProMIS Neurosciences announces formation of prestigious Scientific Advisory and Business Advisory Boards 49

Appendix 50

Methodology 50

About GlobalData 50

Contact Us 50

Disclaimer 50

List of Figures

ProMIS Neurosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

ProMIS Neurosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

ProMIS Neurosciences Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

ProMIS Neurosciences Inc, Medical Equipment, Key Facts, 2015 1

ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

ProMIS Neurosciences Inc, Deals By Market, 2011 to YTD 2017 9

ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11

Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 12

Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 13

Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 13

ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 14

ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 16

ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 17

ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 18

ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 19

Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 20

Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 21

Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 22

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 23

Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 24

Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 25

Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 25

Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 26

Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 27

Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 28

ProMIS Neurosciences Inc, Key Competitors 31

ProMIS Neurosciences Inc, Key Employees 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com